Global STD Diagnostics Market is expected to reach USD 200.9 billion by 2022 according to a new study by Grand View Research Inc. The rising geriatric population base, increasing global incidence of various STIs, rise in sedentary lifestyle adoption levels, and rising awareness & patient education are the driving forces for the STD diagnostics market growth over the forecast period.
Increasing
number of people having multiple partners and low levels of infection awareness
levels are the major drivers fueling industrial growth. Increasing demand for
rapid and accurate diagnostic tests and presence of favorable government
initiatives for STD testing in developing countries such as Brazil, India, and
China are further estimated to boost market growth.
Browse
Details of Report @
http://www.grandviewresearch.com/industry-analysis/diagnostic-testing-of-stds-market
Further key findings from the study suggest:
- Chlamydia
testing accounted for over 34% of the market in 2014. Chlamydia testing
for sexually active women aged below 25 years is strictly recommended by
the U.S Preventive Services Task Force (PSTF). Syphilis testing is
estimated to witness lucrative growth over the forecast period. It is
anticipated to grow at a CAGR of 10% owing to increasing prevalence of
syphilis infection globally.
- On the basis
of test location, laboratory testing held the largest market share of over
63% in 2014 owing to the availability of cost effective diagnostic tests
used for multiple STIs at a single location such as public health labs.
Point of care on the other hand is anticipated to be the fastest growing
segment over the forecast period owing to the owing to the introduction of
CLIA waived tests
- Laboratory
testing devices dominated the market in 2014 with revenue generation of
over 67.0 billion. Immunochromatographic assays were most preferred
devices for STD diagnosis in laboratory with revenue share of over 26%.
Increasing technological advancements are estimated to enhance usage rates
of thermal cyclers over the forecast period.
- Portable/bench
top or rapid diagnostic kits are estimated to gain demand over the forecast
period owing to features such as user-friendliness, increasing awareness
pertaining to self testing, and fast results.
- North
America held the largest share of the STD diagnostics market with revenue
generation of over 32 billion in 2014. Introduction of technologically
advanced diagnostics techniques such as immunochromatographic device by
Chembio Diagnostics Systems Inc. is the major factor attributing for its
largest market share.
- Asia Pacific
region is estimated to witness significant growth over the forecast period
owing to the presence of high amount of target population, rising
awareness levels for STIs, and increasing government initiatives and rise
in disposable income expenditure levels. Asia Pacific is expected to show
double digit CAGR growth over the forecast period.
- Major
companies of the STD diagnostics industry include Roche Holdings AG,
Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Danaher
Corporation, Affymetrix, BioMerieux, Cepheid Inc., Alere Inc., DiaSorin,
and Orasure
- Licensing
and partnership deal making activities in the molecular diagnostics sector
are growing significantly in terms of value. New entrants such as life
science research groups, financial investors, clinical laboratories, and
medical technology players drive up the values.
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment